Inside Drug Pricing - 02/12/2019

Newly Introduced CREATES Act Could Be Decoupled From Donut Hole Fix

By Rachel Cohrs
February 6, 2019 at 11:14 AM
NEW ORLEANS -- Senate Finance Committee Chairman Sen. Chuck Grassley (R-IA) and Sen. Patrick Leahy (D-VT) introduced a bill Tuesday (Feb. 5) that they say would lower drug prices by blocking tactics brand-drug makers use to delay generic drug development by withholding drug samples. The Creating and Restoring Equal Access to Equivalent Samples Act was previously considered as an option for the brand-drug lobby to pay for lowering its share of Medicare Part D coverage gap costs, but there may...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.